Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)-a phase III, prospective, multicentre, randomized study: design and methods.
Leonard M CoulibalyStefan SacuPhilipp FuchsHrvoje BogunovicGeorg FaustmannChristian UnterrainerGregor Sebastian ReiterUrsula Margarethe Schmidt-ErfurthPublished in: Eye (London, England) (2022)
EudraCT-Number: 2019-003133-42.